Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine
2021-05-23 00:00
Concord Medical Announces Changes in Board of Directors
2021-05-22 04:15
CUREXO's spinal surgery robot, 'CUVIS-spine' acquired FDA (US) licensing.
2021-05-22 03:52
Kintor Announced (1) FDA Has Greenlighted Proxalutamide's Phase III Study for Hospitalized Male and Female COVID-19 Patients to Be Conducted; and (2) Inclusion of Female Outpatients in Proxalutamide's Phase III Study for Mild to Moderate COVID-19
2021-05-20 09:47
Duality Biologics Completed $90 Million Series B Financing
2021-05-20 08:00
I-Mab Presents Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021
2021-05-20 06:00
Gracell Biotechnologies to Present Updated Results of GC012F FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma at ASCO 2021 and EHA 2021
2021-05-20 05:15
United Imaging at CMEF Announces uAIFI Technology Platform and uExcel Technology Platform that Advance MR and MI
2021-05-19 23:32
ThinkCyte Secures $26 million in Series B Financing
2021-05-19 22:00
Island Pharmaceuticals granted key patent for ISLA-101 in the United States
2021-05-19 19:30
111, Inc. Announces First Quarter 2021 Unaudited Financial Results
2021-05-19 14:17
GeneQuantum Raises Hundreds of Millions RMB in Series C Funding
2021-05-19 10:30
Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London
2021-05-17 16:00
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue
2021-05-15 04:30
Arctic Vision announces exclusive licensing agreement with ActualEyes
2021-05-14 20:00
Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021
2021-05-14 11:58
Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations
2021-05-14 10:33
I-Mab Added to MSCI China Index
2021-05-13 20:00
An oral antiviral drug from Korea may be a problem solver for COVID-19
2021-05-13 16:37
Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
2021-05-13 15:21
1
164
165
166
167
168
422